Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 9 | 0 | €1,087.0 | €1,091.9 | 0.453% |
| Eli Lilly Corp. | 69 | 0 | 10 | 0 | €857.80 | €860.00 | 0.256% |
| arGEN X BV | 1 | 0 | 0 | 0 | €462.50 | €470.00 | 1.622% |
| Vertex Pharmaceuticals Inc. | 59 | 2 | 7 | 0 | €449.40 | €450.36 | 0.215% |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | €346.30 | €418.12 | 20.740% |
| United Therapeutics | 27 | 1 | 5 | 1 | €330.30 | €332.33 | 0.615% |
| Icon plc | 24 | 0 | 0 | 0 | €288.10 | €326.21 | 13.228% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €225.80 | €315.00 | 39.504% |
| Amgen Inc. | 28 | 0 | 3 | 0 | €300.55 | €304.82 | 1.420% |
| Alnylam Pharmace. | 45 | 0 | 7 | 0 | €259.00 | €275.25 | 6.274% |
| BeiGene Ltd ADR | 10 | 1 | 2 | 0 | €179.00 | €238.56 | 33.276% |
| Zoetis Inc. A | 25 | 1 | 4 | 0 | €166.34 | €198.11 | 19.101% |
| Novo Nordisk A/S | 6 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Johnson & Johnson | 40 | 1 | 4 | 0 | €148.50 | €187.62 | 26.340% |
| Krystal Biotech | 20 | 0 | 4 | 0 | €184.55 | €186.59 | 1.105% |
| Jazz Pharmaceuticals plc | 30 | 0 | 6 | 0 | €104.70 | €183.41 | 75.181% |
| AbbVie Inc. | 34 | 0 | 3 | 0 | €177.00 | €180.90 | 2.205% |
| Repligen Corp. | 15 | 0 | 4 | 0 | €130.50 | €178.01 | 36.408% |